Acasti Pharma Inc. (ACST) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Laval, QC, 加拿大. 现任CEO为 Prashant Kohli.
ACST 拥有 IPO日期为 2012-02-07, 32 名全职员工, 在 NASDAQ Capital Marke, 市值为 $34.17M.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
